Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$7.6 - $10.28 $100,160 - $135,480
-13,179 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$9.81 - $13.88 $129,285 - $182,924
13,179 New
13,179 $132,000
Q4 2020

Feb 11, 2021

SELL
$9.47 - $12.43 $107,692 - $141,353
-11,372 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$8.15 - $21.17 $92,681 - $240,745
11,372 New
11,372 $100,000

Others Institutions Holding NXTC

About NextCure, Inc.


  • Ticker NXTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,748,800
  • Market Cap $36.4M
  • Description
  • NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...
More about NXTC
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.